Search results
Results from the WOW.Com Content Network
Once insulin binds to the receptor, phosphorylation takes place and attaches to the beta-subunit, thus initiating the transduction process. A protein binds to the phosphorylated receptor protein, becoming phosphorylated as well.
The insulin transduction pathway is a biochemical pathway by which insulin increases the uptake of glucose into fat and muscle cells and reduces the synthesis of glucose in the liver and hence is involved in maintaining glucose homeostasis. This pathway is also influenced by fed versus fasting states, stress levels, and a variety of other ...
The insulin receptor (IR) is a transmembrane receptor that is activated by insulin, IGF-I, IGF-II and belongs to the large class of receptor tyrosine kinase. [5] Metabolically, the insulin receptor plays a key role in the regulation of glucose homeostasis; a functional process that under degenerate conditions may result in a range of clinical manifestations including diabetes and cancer.
This page is the template for the metabolic pathways template. This template should be used to illustrate the general 'shape' of metabolism within the cell . This template is part of the Metabolic Pathways task force .
In cell biology, there are a multitude of signalling pathways. Cell signalling is part of the molecular biology system that controls and coordinates the actions of cells.. Akt/PKB signalling pathway
The upstream signaling pathway is triggered by the binding of a signaling molecule, a ligand, to a receiving molecule, a receptor. Receptors and ligands exist in many different forms, and only recognize/bond to particular molecules. Upstream extracellular signaling transduce a variety of intracellular cascades. [1]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
GLP-1 receptor agonists stimulate insulin secretion by simulating activation of the body's endogenous incretin system. [32] The incretin system acts as an insulin secretion amplifying pathway. [32] DPP-4 inhibitors block DPP-4 activity which increases postprandial incretin hormone concentration, therefore increasing insulin secretion. [32]